ESR1 and osteoporosis: Raloxifene is a selective modulator of estrogen receptors, with an estrogen-agonistic effect on bone, and an estrogen-antagonistic effect in the uterus and breast, used for the treatment of osteoporosis in postmenopausal women [54].